Christy Cappelletti, PharmD

Senior Group Director, Late Stage Development, Late Respiratory, Immunology, and Infection
BioPharmaceuticals R&D, AstraZeneca, Durham, NC, United States

Poster(s):

• (404) Efficacy of as-needed albuterol–budesonide versus albuterol on systemic corticosteroid exposure in participants with mild asthma: BATURA prespecified analysis
  Wednesday, October 29, 2025